W. Gerald

Molecular Biology · 2001–2011

A researcher in the Science corpus: 19 papers; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 130 citations into it; #10,773 of 17,773 by trust here, #583 by citations
• Oncology — 87 citations into it; #830 of 1,698 by trust here, #149 by citations

Whom W. Gerald trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. J. Massagué

Who trusts W. Gerald overall

1. J. Massagué
2. D. Nguyen

Papers from W. Gerald's perspective

Ordered by how strongly the researchers W. Gerald trusts endorse each paper. Same corpus, a different order for every researcher.

1. A multigenic program mediating breast cancer metastasis to bone. (Cancer Cell)
2. Gene expression profiling predicts clinical outcome of breast cancer
3. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression (Proceedings of the National Academy of Sciences of the United States of America)
4. WNT and β-catenin signalling: diseases and therapies (Nature reviews genetics)
5. The many ways of Wnt in cancer. (Current Opinion in Genetics and Development)
6. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. (Cell)
7. Wnt signalling and its impact on development and cancer (Nature Reviews. Cancer)
8. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice (Nature)
9. Interleukin-6: from basic science to medicine--40 years in immunology. (Annual Review of Immunology)
10. Identification of bronchioalveolar stem cells in normal lung and lung cancer. (Cell)

Their papers

• Multiclass cancer diagnosis using tumor gene expression signatures (2001) — 2,146 citations
• Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis (2005) — 2,078 citations
• Endogenous human microRNAs that suppress breast cancer metastasis (2008) — 1,907 citations
• Genes that mediate breast cancer metastasis to lung (2005) — 3,095 citations
• Inactivation of the apoptosis effector Apaf-1 in malignant melanoma (2001) — 1,008 citations
• Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate (2009) — 692 citations
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways (2008) — 7,050 citations
• Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. (2005) — 737 citations
• WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis (2009) — 610 citations
• Gene Expression-Based Survival Prediction in Lung Adenocarcinoma: A Multi-Site, Blinded Validation Study (2008) — 1,144 citations
• MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells (2001) — 801 citations
• Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. (2004) — 602 citations
• Identification of DOK family genes as lung tumor suppressors (2010) — 122 citations
• Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases (2011) — 962 citations
• Integrative genomic profiling of human prostate cancer (2010) — 3,651 citations
• Genes that mediate breast cancer metastasis to the brain (2009) — 1,825 citations
• TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. (2008) — 986 citations
• MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib (2007) — 1,698 citations
• Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. (2007) — 675 citations